Skip to content
Home » Bracco Japan Co., Ltd. Notice regarding the merger of Bracco Japan and Assist Japan

Bracco Japan Co., Ltd. Notice regarding the merger of Bracco Japan and Assist Japan

Bracco Japan Co., Ltd.
Notice regarding the merger of Bracco Japan and Assist Japan ……
[Image: https://prtimes.jp/i/95669/13/resize/d95669-13-23923a5326876db982d9-2.png&s3=95669-13-477aaacdca5d7b9dc42620a53217fca1-946×138.png ]
Announcement regarding the merger of Bracco Japan and Assist Japan Bracco Japan Co., Ltd. (Head office: 1-13-21 Minamiikebukuro, Toshima-ku, Tokyo, PMO Ikebukuro II, President and CEO: Tetsuaki Sakamoto, hereinafter referred to as Bracco Japan) and Assist Japan We would like to inform you that Assist Japan Co., Ltd. (Head office: PMO Ikebukuro II, 1-13-21 Minami-Ikebukuro, Toshima-ku, Tokyo, President and CEO: Tetsusho Sakamoto, hereinafter referred to as Assist Japan) will merge on July 1, 2024. The surviving company will be Bracco Japan. Bracco Japan was established in 1990 as a joint venture between Bracco Imaging S.p.A. (Headquarters: Milan, Italy, CEO: Fulvio Renoldi Bracco, hereinafter referred to as Bracco) and Eisai Co., Ltd. (Headquarters: Tokyo, Representative Executive Officer and CEO: Haruo Naito, hereinafter referred to as Eisai). Since our start as a company, we have been manufacturing and selling high-quality pharmaceuticals in the field of diagnostic imaging for over 30 years. In March 2023, the joint venture with Eisai was dissolved, and from April 2024, Bracco Japan will begin selling the product independently, delivering it to medical professionals. Assist Japan was established in May 2007 as the Japanese subsidiary of Bracco Medical Technologies (Headquarters: Eden Prairie, USA; CEO: Bradley C. Fox), a pioneer and world leader in advanced imaging modalities in the field of cardiac diseases. I did. In June 2017, we began direct sales of medical devices including automatic contrast agent injection devices, and have provided medical professionals with solutions that simplify
cardiovascular interventions and diagnostic procedures. . Through this merger, both companies, which are Bracco group companies, will be able to bring together not only their own products but also the knowledge and experience they have accumulated over many years. We can deliver it to everyone. Tetsuaki Sakamoto, President and Representative Director of Bracco Japan, said, “For many years, we have provided solutions in the diagnostic imaging and interventional fields through the sale of high-quality pharmaceuticals and medical devices in Japan. This merger will create a system that maximizes the strengths of Bracco Japan and Assist Japan, and will benefit medical professionals who are involved in the diagnosis and treatment of patients on a daily basis. We strongly believe that we can provide not only superior products but also new added value.In Japan’s rapidly aging society, there is an increasing need for early diagnosis and early treatment, including diagnostic imaging. Through this merger, we will continue to work even harder to fulfill Bracco’s purpose of creating the future of preventive medicine and precision imaging and improving people’s lives.” I am. About Bracco Japan Co., Ltd. Bracco Japan Co., Ltd. is the Japanese subsidiary of Italy’s Bracco Imaging Holding B.V., a member of the Bracco Group and a world leading company in the field of diagnostic imaging. In Japan, we manufacture and sell high-quality pharmaceuticals that provide solutions in the field of diagnostic imaging, and deliver them to medical professionals who are involved in the diagnosis and treatment of patients on a daily basis.
https://www.bracco.com/jaAbout Bracco Group Bracco is a multinational conglomerate founded in 1927 and headquartered in Milan, Italy. The company is active in the healthcare field through Bracco Imaging (diagnostic imaging), Bracco Medical Technologies (cardiology) and Centro Diagnostico Italiano (diagnostic clinic). The company has approximately 3,700 employees, operates in more than 100 countries around the world, and has annual consolidated sales of more than 1.7 billion euros. https://www.bracco.com/enFor press inquiries regarding this matter, please contact Bracco Japan Co., Ltd. Public Relations TEL: 03-5319-3381

More details about this release:
https://prtimes.jp/main/html/rd/p/000000013.000095669.html